Oslo, 10 June 2026 - Observe Medical ASA (OSE: OBSRV) ("the Company" or "Observe Medical") is pleased to host a presentation with trading update Friday, 26 June 2026.
Observe Medical invites investors, analysts, and other stakeholders to the presentation which will take place virtually Friday 26 June 2026, at 10:00 CEST, and streamed via webcast at the following link: https://qcnl.tv/p/eTRN97XxaZRzl4F69giI4Q
The main focus will be an update on our inbound order trajectory and the first impressions from the commercial launch of UnoMeter Safeti Max.
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.